Meeder Asset Management Inc Cti Biopharma Corp Transaction History

Meeder Asset Management Inc

  • $1.48 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 16, 2019
SELL
$0.9 - $1.37 $1,269 - $1,931
-1,410 Closed
0 $0
Q4 2018

Jan 17, 2019
SELL
$0.73 - $2.19 $494 - $1,482
-677 Reduced 32.44%
1,410 $1,000
Q3 2018

Nov 02, 2018
BUY
$1.72 - $5.24 $3,589 - $10,935
2,087 New
2,087 $0

About CTI BIOPHARMA CORP

CTIC Quotes by TradingView
  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email